Tag: CDISC

Clinical

Streamlining Drug Development with PK Submit™: Automating CDISC Domain Creation for Regulatory Submissions

Streamlining Drug Development with PK Submit™: Automating...

Hema Dubey Apr 26, 2023 0 4016

PK Submit™ is a software tool that automates the creation of CDISC domains for regulatory...

Clinical

Vaccines and Drugs under clinical trials for COVID 19

Vaccines and Drugs under clinical trials for COVID 19

Meghana Apr 14, 2020 0 3535

The coronavirus disease (COVID-19) virus is spreading rapidly, and scientists are...

GVHS2021

Dr. Keith Nieforth - GVHS 2021 Speaker

Dr. Keith Nieforth - GVHS 2021 Speaker

Meghana Jul 14, 2021 0 3582

AKT Health Analytics brings to you Global Virtual Healthcare Summit #GVHS2021 -...

Clinical

Remdesivir for Coronavirus

Remdesivir for Coronavirus

Meghana May 6, 2020 0 4211

Currently remdesivir has not been approved by health authorities around the world,...

Thoughts from AKTHealth

Certara - Pinnacle 21

Certara - Pinnacle 21

Meghana Jul 25, 2022 0 4039

AKT Health Analytics has partnered with Certara. We are the sole promoters and distributors...

Clinical

FDA Issues Guidelines for conducting Covid 19 Trials

FDA Issues Guidelines for conducting Covid 19 Trials

Meghana Apr 11, 2020 0 4750

The FDA protects the public health by assuring the safety, effectiveness, and security...

GVHS2022

GVHS2022 Speaker : Aditya Tallapragada

GVHS2022 Speaker : Aditya Tallapragada

Hema Dubey Nov 11, 2022 0 2119

Aditya Tallapragada Co-Founder and CEO of MEDIFAKT and President of AKT Health Inc....

Technology

Certara Launches New Synchrogenix™ Writer Software

Certara Launches New Synchrogenix™ Writer Software

Meghana Jun 15, 2022 0 4226

Certara’s Synchrogenix™ Writer is designed specifically to assist your medical writers...

Thoughts from AKTHealth

How to Take Care of Employees Returning to Work During COVID – 19 Pandemic?

How to Take Care of Employees Returning to Work During...

Vijay May 26, 2020 0 4035

During these pandemic times, the entire globe implemented emergencies and lockdowns...

GVHS2022

GVHS2022 Speaker: Dr. Eiji Sasahara

GVHS2022 Speaker: Dr. Eiji Sasahara

Hema Dubey Nov 11, 2022 0 1998

Dr. Eiji Sasahara, Ph.D., MBA, Partner of Healthcare Cloud Initiative, NPO will...

GVHS2022

GVHS2022 Speaker : Dr. Mitsuhiro Marumoto

GVHS2022 Speaker : Dr. Mitsuhiro Marumoto

Hema Dubey Nov 11, 2022 0 2271

Dr. Mitsuhiro Marumoto Country Manager of AKT Health will be speaking at our 3rd...

What is the impact of your current operational response to COVID-19?

Minimum impact, most employees can work from home

Moderate impact, some employees need to work on-site

Significant impact, most employees need to work on-site

Total impact, complete shut down

Please select an option!

You already voted this poll before.

What is the impact of your current operational response to COVID-19?

Total Vote: 2

Minimum impact, most employees can work from home

0 %

Moderate impact, some employees need to work on-site

50 %

Significant impact, most employees need to work on-site

50 %

Total impact, complete shut down

0 %